FDA to Tackle ‘Anti-Competitive’ Citizen Petitions by Drugmakers

September 12, 2018

The Food and Drug Administration (FDA) will soon revise its policy on citizen petitions, which can be “another anti-competitive technique” drugmakers use to block generic approval, an FDA official said on Sept. 5.

Related Stories